Robert Carradine, Bipolar Disorder
Digest more
The FDA OKs pill schizophrenia and bipolar disorder treatment with Bysanti, a new atypical antipsychotic approved for adults.
Milsaperidone, a new chemical entity, is the major active metabolite of iloperidone (Fanapt) and had been demonstrated to be bioequivalent to iloperidone.
Teens who use weed are twice as likely to develop psychotic or bipolar disorders, a new study says. They also are more likely to have depression and anxiety, researchers reported Feb. 20 in JAMA Health Forum.
MedPage Today on MSN
New Pill Approved for Schizophrenia, Bipolar Disorder
Milsaperidone is an active metabolite of iloperidone
A new study finds teen cannabis use may be linked to a doubled risk of serious mental illness, including psychosis and bipolar disorder.